JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its first quarter 2010 financial results on Tuesday, May 4, 2010.
Teva will host a conference call and live webcast on the same day, at 9:00 a.m. ET to discuss its first quarter 2010 results and overall business environment. A Question & Answer session will follow this discussion. The earnings release will be available on Teva's web site at www.tevapharm.com prior to the call.
Investors and other interested parties may access a live webcast through Teva's website at www.tevapharm.com. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the webcast will be available within 24 hours on the Company's website. Alternatively, a replay of the call can be accessed until May 11, 2009, at 11:59 p.m. ET, by calling (201) 612-7415 or (877) 660-6853. The Pass Code to access the replay: account #3055 and conference ID #349279.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.
Teva Pharmaceutical Industries Ltd.
Elana Holzman, 972 (3) 926-7554
Teva North America
Kevin Mannix, 215-591-8912
KEYWORDS: United States North America New York Middle East Israel
INDUSTRY KEYWORDS: Health Pharmaceutical